Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke
Stroke - United States
doi 10.1161/strokeaha.114.005852
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2014
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)